The Stanford Hypertension Center
Innovative care for a familiar condition
Nationally Designated Hypertension Center
American Society of Hypertension (ASH) Certification
The Stanford Hypertension Center is certified as a Comprehensive Hypertension Center by the American Society of Hypertension (ASH).
Features of the Center
- A multidisciplinary forum for discussion of challenging cases (akin to Tumor Board for Oncology)
- Group classes for patients
- If needed, genetic counseling services are available
- An avenue for clinical and translational research
- An avenue for medical device testing
We specialize in diagnosis and management of difficult-to-control or resistant hypertension. For patients with three or more drugs including a diuretic ("water pill"), intolerance to antihypertensive medications, suspicion of secondary cause, or a strong family history of hypertension, consider a referral.
The Director's Mission Statement
We created this multidisciplinary Center to provide comprehensive, high-quality, and innovative care for patients with severe or refractory hypertension, including evaluation for secondary and reversible forms of hypertension. The Center integrates the referral process and provides consultation, diagnostic testing, and therapies for a variety of conditions that can cause and / or exacebate hypertension and provide feedback to referring physicians after evaluation and treatment.
Vivek Bhalla, MD, FASN; Director, Stanford Hypertension Center
Partners in Clinical Care
We have partnered with colleagues to provide smooth transitions of care. For example, with Stanford Primary Care, to provide the next level of service if guideline and protocol-based treatment has not controlled blood pressure; and with Stanford Neurology through the nationally renowned Stanford Stroke Center, to provide a resource for blood pressure control post-stroke.
The Stanford Stroke Center is a nationally recognized center of excellence for stroke care. Primary prevention of stroke by control of blood pressure is highly effective with efficacy that is well established in multiple clinical trials (reviewed by Rashid, et al, Stroke, 2003). Patients with resistant hypertension are also at higher risk of stroke than patients with less severe forms of hypertension. However, many of these patients are not receiving sufficient blood pressure lowering therapies (Calhoun, et al, Hypertension, 2014). Thus, the Stanford Hypertension Center has partnered with the Stanford Stroke Center to care for patients with resistant hypertension. Our hypertension specialists provide a comprehensive diagnostic screen for secondary causes of hypertension and use anti-hypertensive medications and complementary therapies to reduce the risk of future strokes.
Gregory W Albers, MD Director, Stanford Stroke Center Professor of Neurology and Neurological Sciences
Partners in Clinical / Translational Research
We have also partnered with several academic research organizations at Stanford. These innovative Centers house the infrastructure to advance clinical and translational research for hypertension, and we look forward to working with our colleagues on novel and exciting studies.